Overview
Cardiologs provides an AI-powered platform for medical-grade ECG analysis that helps clinicians diagnose and manage cardiovascular diseases. It automatically analyzes ECG recordings to detect more than 20 types of arrhythmia events and delivers clinically validated reports that fit into routine workflows. Healthcare professionals upload ECG data to Cardiologs’ platform, where the AI processes signals and generates actionable insights, with the service available on a subscription basis for institutions and clinicians. The company's goal is to improve diagnostic precision and patient care worldwide by offering scalable, automated ECG analysis that integrates into everyday clinical practice.
Work here?Claim your company
Simplify's take
What believers are saying
- Philips still marketed Cardiologs Holter on 2026-11-09, signaling active commercialization.
- Philips positions Cardiologs within its cardiac care portfolio, expanding distribution globally.
- Vendor-neutral API integration supports smartwatch, patch, and Holter workflows.
What critics are saying
- Philips controls Cardiologs now, so priorities can shift away from standalone growth.
- Medtech rivals like iRhythm and Cardiac Insight attack the same ECG workflow.
- If Philips de-emphasizes Cardiologs, the product becomes a niche feature, not a company.
What makes Cardiologs unique
- Philips’ Cardiologs Holter runs vendor-neutral SaaS across connected computers, no local installs.
- Its deep neural networks detect 20-plus arrhythmias from continuous ambulatory ECGs.
- Philips says it cuts Holter analysis time about 42% for clinicians.
Help us improve and share your feedback! Did you find this helpful?